Long Ideas

Needham Likes Genocea Biosciences Inc (GNCA) Potential for Upside Following R&D Day; Shares Rise 8%

Genocea Biosciences Inc (NASDAQ:GNCA) shares are surging nicely ahead 8% today after the firm hosted an R&D day yesterday via a webinar providing …

Cantor Remains Confident on Pacific Biosciences of California (PACB) While Shares Crash 42%

Pacific Biosciences of California (NASDAQ:PACB) shares are on a 42% nosedive after announcing this morning before market open that Roche has terminated its collaboration …

Brean Capital Highlights Key Takeaways on Baidu Inc (ADR) (BIDU) Following Group Investor Conference Call

Brean Capital analyst Fawne Jiang is confident on Baidu Inc (ADR) (NASDAQ:BIDU) after hosting a group investor conference call yesterday with Linda Sun …

Cowen Reiterates Positive Stance on Netflix, Inc. (NFLX) Ahead of Prospective Charter Integration

Cowen analyst John Blackledge is all the more bullish on Netflix, Inc. (NASDAQ:NFLX) following CEO of Charter Tom Rutledge’s recent comments at an …

William Blair Boosts Price Target for Achaogen Inc (AKAO) as EPIC and CARE Top-Line Data Exceeds Expectations

Achaogen Inc (NASDAQ:AKAO) shares rose 14% today after the company reported positive top-line results from the phase 3 trial of its treatment for urinary …

Roth Capital Sees Room for Optimism Following bluebird bio Inc (BLUE) ASH Read-Out

During last week’s American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, bluebird bio Inc (NASDAQ:BLUE) provided clinical updates on …

H.C. Wainwright Chimes in on OHR Pharmaceutical Inc (OHRP) and the Implications of Fovista’s Failings

OHR Pharmaceutical Inc (NASDAQ:OHRP) is confronting the aftermath of Fovista’s pivotal two Phase 3 failures that both missed the primary endpoint in neovascular …

Jefferies Analyst Sees Long-Term Growth Potential for Horizon Pharma PLC (HZNP) Despite Actimmune FA Phase 3 Flop

Horizon Pharma PLC (NASDAQ:HZNP) has had a recent misstep on its hands with a Phase 3 flop in its Actimmune Friedrich’s Ataxia (FA) …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts